Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer Patients
Trends of Mastectomy and Breast-Conserving Surgery and Related Factors in Female Breast Cancer Patients Treated at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, 2009-2017
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Mecca
-
Jeddah, Mecca, Saudi Arabia, 00966
- Faculty of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Female, diagnosed with breast cancer, underwent surgery on the breast tumor in King Abdulaziz University Hospital
Exclusion Criteria:
- Patients with metastatic breast cancer or recurrence of the cancer before the surgery
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Mastectomy
|
Removal of the whole breast
|
|
Breast-Conserving Surgery
|
Removal of the cancerous tissue only
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of each of mastectomy and breast-conserving surgery
Time Frame: 2009-2017
|
The percentage of of patients who underwent each surgery
|
2009-2017
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The relationship between the choice of procedure and the patients' age (in years)
Time Frame: 2009-2017
|
Statistical analysis using independent sample T-test and binary logistic regression
|
2009-2017
|
|
The relationship between the choice of procedure and the use of preoperative chemotherapy (also called "neoadjuvant chemotherapy")
Time Frame: 2009-2017
|
Statistical analysis using Chi-square test and binary logistic regression
|
2009-2017
|
|
The relationship between the choice of procedure and the tumor's laterality (right versus left breast cancer)
Time Frame: 2009-2017
|
Statistical analysis using Chi-square test and binary logistic regression
|
2009-2017
|
|
The relationship between the choice of procedure and the tumor's focality (whether it is composed of more than one mass)
Time Frame: 2009-2017
|
Statistical analysis using Chi-square test and binary logistic regression
|
2009-2017
|
|
The relationship between the choice of procedure and the tumor's centricity (whether it involves more than one quadrant of the breast)
Time Frame: 2009-2017
|
Statistical analysis using Chi-square test and binary logistic regression
|
2009-2017
|
|
The relationship between the choice of procedure and the tumor's size (in centimeters)
Time Frame: 2009-2017
|
Statistical analysis using independent sample T-test and binary logistic regression
|
2009-2017
|
|
The relationship between the choice of procedure and the tumor's stage (using the 7th "American Joint Committee on Cancer"'s staging guidelines)
Time Frame: 2009-2017
|
Statistical analysis using Chi-square test and binary logistic regression
|
2009-2017
|
|
The relationship between the choice of procedure and the tumor's histological grade (using the Nottingham Histologic Score system)
Time Frame: 2009-2017
|
Statistical analysis using Chi-square test and binary logistic regression
|
2009-2017
|
|
The relationship between the choice of procedure and the tumor's receptor status (whether it is positive for estrogen, progesterone, and/or human epidermal growth factor receptor 2)
Time Frame: 2009-2017
|
Statistical analysis using Chi-square test and binary logistic regression
|
2009-2017
|
|
The relationship between the choice of procedure and having preoperative magnetic resonance imaging of the breast and its findings
Time Frame: 2009-2017
|
Statistical analysis using Chi-square test and binary logistic regression
|
2009-2017
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 357-71
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.